646 related articles for article (PubMed ID: 21671061)
1. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
Walia B; Satija N; Tripathi RP; Gangenahalli GU
Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
[TBL] [Abstract][Full Text] [Related]
2. Progress in the reprogramming of somatic cells.
Ma T; Xie M; Laurent T; Ding S
Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying the formation of induced pluripotent stem cells.
González F; Huangfu D
Wiley Interdiscip Rev Dev Biol; 2016; 5(1):39-65. PubMed ID: 26383234
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and methods to induce pluripotency.
Wang P; Na J
Protein Cell; 2011 Oct; 2(10):792-9. PubMed ID: 22058034
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
Shtrichman R; Germanguz I; Itskovitz-Eldor J
Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
7. Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality.
Cao S; Loh K; Pei Y; Zhang W; Han J
Protein Cell; 2012 Nov; 3(11):834-45. PubMed ID: 23073833
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
[TBL] [Abstract][Full Text] [Related]
9. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
Lewandowski J; Kurpisz M
Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.
Maali A; Maroufi F; Sadeghi F; Atashi A; Kouchaki R; Moghadami M; Azad M
Epigenomics; 2021 Apr; 13(8):631-647. PubMed ID: 33823614
[TBL] [Abstract][Full Text] [Related]
11. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
12. Effect of small molecules on cell reprogramming.
Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
14. An Insight into Reprogramming Barriers to iPSC Generation.
Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
[TBL] [Abstract][Full Text] [Related]
15. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in regulation of pluripotency and somatic cell reprogramming: small molecule with big impact.
Wang T; Shi SB; Sha HY
RNA Biol; 2013 Aug; 10(8):1255-61. PubMed ID: 23921205
[TBL] [Abstract][Full Text] [Related]
17. Steps toward safe cell therapy using induced pluripotent stem cells.
Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells in regenerative medicine and disease modeling.
Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
[TBL] [Abstract][Full Text] [Related]
19. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
20. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
